-
PDF
- Split View
-
Views
-
Cite
Cite
Francesco Giorgino, Antonino Belfiore, Giovanni Milazzo, Angela Costantino, Betty Maddux, Jonathan Whittaker, Ira D. Goldfine, Riccardo Vigneri, Overexpression of Insulin Receptors in Fibroblast and Ovary Cells Induces a Ligand-Mediated Transformed Phenotype, Molecular Endocrinology, Volume 5, Issue 3, 1 March 1991, Pages 452–459, https://doi.org/10.1210/mend-5-3-452
- Share Icon Share
To investigate whether overexpression of the insulin receptor results in altered cell growth we used NIH 3T3 cells transfected with a bovine papilloma virus/insulin receptor cDNA construct (3T3/HIR). These cells expressed high numbers of insulin receptors (mean ± sd, 631.0 ± 16.7 ng receptors/106 cells). Insulin significantly stimulated the growth of 3T3/HIR cells maintained in serum-free medium. Moreover, in these cells, insulin induced marked phenotypic changes, including alterations in cell shape, loss of contact inhibition, and focal growth. In contrast to 3T3/HIR cells, insulin was without effect in either wild-type 3T3 cells (3T3/wt), 3T3 cells transfected with the neomycin resistance gene (3T3/NEO), or the bovine papilloma virus (3T3/BPV).
To assess the presence of anchorage-independent growth, cells were seeded in soft agar and inspected for colony formation. 3T3/HIR cells showed absent or minimal colony growth in the absence of insulin. However, there was a dose-dependent insulin-stimulated increase in both colony size and number. Insulin-stimulated colony formation was specifically inhibited by an insulin antagonist, monoclonal antibody MA-10. In the presence of 100 nM insulin, about 3% of cells formed large colonies. Insulin neither stimulated growth nor induced colony formation in 3T3/wt cells or 3T3/NEO cells. Insulin also stimulated colony formation in CHO cells transfected with an insulin receptor cDNA construct. In conclusion, overexpression of normal insulin receptors induces a ligand-dependent transformed phenotype. This phenomenon may have clinical relevance by conferring a selective growth advantage to tumor cells with high numbers of insulin receptors.
Author notes
This work was supported in part by a grant from the AIRC (Associazione Italiana per la Ricerca sul Cancro), NIH Grant DK-42171, and the John A. Kerner Foundation.
Recipients of AIRC fellowships.